Literature DB >> 19383323

The Stockholm declaration.

Ulrik Ringborg.   

Abstract

Mesh：

Year:  2008        PMID： 19383323      PMCID： PMC5527785          DOI： 10.1016/j.molonc.2008.03.004

Source DB:  PubMed          Journal:  Mol Oncol        ISSN： 1574-7891            Impact factor:   6.603


× No keyword cloud information.
  10 in total

1.  Turning the Stockholm Declaration into reality: Creating a world-class infrastructure for cancer research in Europe.

Authors:  Hannah Brown
Journal:  Mol Oncol       Date:  2008-11-17       Impact factor: 6.603

2.  'Tackling cancer in the EU: the role of innovation'.

Authors:  Georgs Andrejevs; Julio E Celis; Guido Guidi; Alojz Peterle; Richard Sullivan; Roger Wilson
Journal:  Mol Oncol       Date:  2008-12-25       Impact factor: 6.603

3.  Looking back, to go forward.

Authors:  José M A Moreira
Journal:  Mol Oncol       Date:  2014-03-21       Impact factor: 6.603

Review 4.  Towards a mission-oriented approach to cancer in Europe: an unmet need in cancer research policy.

Authors:  Julio E Celis; Manuel Heitor
Journal:  Mol Oncol       Date:  2019-02-01       Impact factor: 6.603

5.  In the spotlight: Julio Celis, the Founding Editor of Molecular Oncology.

Authors:  Kevin M Ryan
Journal:  Mol Oncol       Date:  2022-01       Impact factor: 6.603

Review 6.  Assessing excellence in translational cancer research: a consensus based framework.

Authors:  Abinaya Rajan; Carlos Caldas; Henri van Luenen; Mahasti Saghatchian; Wim H van Harten
Journal:  J Transl Med       Date:  2013-10-29       Impact factor: 5.531

7.  A mission-oriented approach to cancer in Europe: a joint mission/vision 2030.

Authors:  Julio E Celis; Dainius Pavalkis
Journal:  Mol Oncol       Date:  2017-11-09       Impact factor: 6.603

8.  Cancer Core Europe: a first step towards a virtual cancer institute in Europe?

Authors:  Julio E Celis; Ulrik Ringborg
Journal:  Mol Oncol       Date:  2014-09-18       Impact factor: 6.603

9.  Shaping science policy in Europe.

Authors:  Julio E Celis; José Mariano Gago
Journal:  Mol Oncol       Date:  2014-03-21       Impact factor: 6.603

Review 10.  Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies.

Authors:  A Rajan; A Berns; U Ringborg; J Celis; B Ponder; C Caldas; D Livingston; R G Bristow; T T Hecht; T Tursz; H van Luenen; P Bono; T Helander; K Seamon; J F Smyth; D Louvard; A Eggermont; W H van Harten
Journal:  Mol Oncol       Date:  2015-12-23       Impact factor: 6.603
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.